Ori Gutwerg

2021

In 2021, Ori Gutwerg earned a total compensation of $1.5M as Senior Vice President, Generics at ANI Pharmaceuticals.

Compensation breakdown

Bonus$355,359
Option Awards$402,152
Salary$355,385
Stock Awards$406,441
Total$1,519,337

Gutwerg received $406.4K in stock awards, accounting for 27% of the total pay in 2021.

Gutwerg also received $355.4K in bonus, $402.2K in option awards and $355.4K in salary.

Rankings

In 2021, Ori Gutwerg's compensation ranked 7,203rd out of 12,415 executives tracked by ExecPay. In other words, Gutwerg earned more than 42.0% of executives.

ClassificationRankingPercentile
All
7,203
out of 12,415
42nd
Division
Manufacturing
3,156
out of 5,505
43rd
Major group
Chemicals And Allied Products
1,392
out of 2,375
41st
Industry group
Drugs
1,239
out of 2,096
41st
Industry
Pharmaceutical Preparations
908
out of 1,546
41st

Pay ratio

Ori Gutwerg's Pay$1,519,337
Median Employee's Pay$50,403
Pay Ratio

30

to 1

In 2021, the annual total compensation of Ori Gutwerg was $1,519,337.

The annual total compensation of the median employee at ANI Pharmaceuticals was $50,403.

The ratio of Ori Gutwerg's pay to the pay of median employee was therefore 30 to one.

Source: SEC filing on March 25, 2022.

Gutwerg's colleagues

We found four more compensation records of executives who worked with Ori Gutwerg at ANI Pharmaceuticals in 2021.

2021

Nikhil Lalwani

ANI Pharmaceuticals

Chief Executive Officer

2021

Stephen Carey

ANI Pharmaceuticals

Chief Financial Officer

2021

James Marken

ANI Pharmaceuticals

Senior Vice President, Operations and Product Development

2021

Christopher Mutz

ANI Pharmaceuticals

Head of Rare Disease

News

You may also like